Home › Funds › Citigroup Inc › VRNA

Citigroup Inc position in VRNA

VERONA PHARMA PLC

Latest position (Q3 2025)231.51K sh
Reported value held$24.70M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 495.45K $2.71M New
Q1 2022 369.01K $1.84M New
Q4 2022 780 $20.38K New
Q1 2023 723 $14.52K Reduce
Q2 2023 1.13K $23.89K Add
Q3 2023 832 $13.56K Reduce
Q4 2023 1.21K $24.02K Add
Q1 2024 247 $3.97K Reduce
Q2 2024 1.48K $21.36K Add
Q3 2024 1.28K $36.85K Reduce
Q4 2024 1.47K $68.08K Add
Q1 2025 1.67K $105.84K Add
Q2 2025 5.38K $509.22K Add
Q3 2025 231.51K $24.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding VRNA

No other tracked fund reports a position in VRNA.

All VRNA fund holders →